VCBeat Health Contact Us
Home World's First! Kelun-Biotech/Merck TROP2 ADC Achieves Dual-Positive Phase III Results in Endometrial Cancer

World's First! Kelun-Biotech/Merck TROP2 ADC Achieves Dual-Positive Phase III Results in Endometrial Cancer

May 18, 2026 23:58 CST Updated May 19, 10:09
Kelun-Biotech

Innovative Drug Developer